Inari Medical Stock Today

NARI Stock  USD 79.97  0.00  0.00%   

Performance

Good

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Inari Medical is trading at 79.97 as of the 26th of February 2025. This is a No Change since the beginning of the trading day. The stock's open price was 79.97. Inari Medical has less than a 18 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 1st of June 2024 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
22nd of May 2020
Category
Healthcare
Classification
Health Care
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. The company has 58.56 M outstanding shares of which 2.48 M shares are now shorted by private and institutional investors with about 0.54 trading days to cover. More on Inari Medical

Moving against Inari Stock

  0.67EXAS EXACT SciencesPairCorr
  0.59TFX Teleflex IncorporatedPairCorr
  0.47DHR DanaherPairCorr
  0.43COO Cooper Companies, Earnings Call TodayPairCorr
  0.43EDIT Editas Medicine Earnings Call TodayPairCorr
  0.37UNH UnitedHealth GroupPairCorr

Inari Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Thematic IdeaMedical Equipment (View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.590.66
Moderately Down
Slightly volatile
Gross Profit Margin0.70.79
Fairly Down
Very volatile
Total Current Liabilities92.2 M87.8 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total160.6 M152.9 M
Sufficiently Up
Slightly volatile
Total Assets814.1 M775.4 M
Sufficiently Up
Slightly volatile
Total Current Assets215.4 M270.9 M
Significantly Down
Slightly volatile
Debt Levels
Inari Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Inari Medical's financial leverage. It provides some insight into what part of Inari Medical's total assets is financed by creditors.
Liquidity
Inari Medical currently holds 32.05 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. Inari Medical has a current ratio of 9.84, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Inari Medical's use of debt, we should always consider it together with its cash and equity.

Change In Cash

(17.97 Million)
Inari Medical (NARI) is traded on NASDAQ Exchange in USA. It is located in 6001 Oak Canyon, Irvine, CA, United States, 92618 and employs 1,300 people. Inari Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.68 B. Inari Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 58.56 M outstanding shares of which 2.48 M shares are now shorted by private and institutional investors with about 0.54 trading days to cover. Inari Medical currently holds about 330.5 M in cash with 35.93 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.19.
Check Inari Medical Probability Of Bankruptcy
Ownership Allocation
Inari Medical has a total of 58.56 Million outstanding shares. The majority of Inari Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inari Medical to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inari Medical. Please pay attention to any change in the institutional holdings of Inari Medical as this could imply that something significant has changed or is about to change at the company. Also note that almost two million six hundred twenty-nine thousand five hundred six invesors are currently shorting Inari Medical expressing very little confidence in its future performance.
Check Inari Ownership Details

Inari Stock Institutional Holders

InstituionRecorded OnShares
Geode Capital Management, Llc2024-12-31
1.2 M
American Century Companies Inc2024-12-31
1.1 M
Millennium Management Llc2024-12-31
950.5 K
Fuller & Thaler Asset Management Inc2024-12-31
870.6 K
Manufacturers Life Insurance Co2024-12-31
842.6 K
Woodline Partners Lp2024-12-31
712.9 K
Dimensional Fund Advisors, Inc.2024-12-31
701.4 K
Northern Trust Corp2024-12-31
693.1 K
Eventide Asset Management, Llc2024-12-31
619.6 K
Blackrock Inc2024-12-31
8.4 M
Vanguard Group Inc2024-12-31
5.6 M
View Inari Medical Diagnostics

Inari Medical Historical Income Statement

As of now, Inari Medical's Selling General Administrative is increasing as compared to previous years. The Inari Medical's current Selling And Marketing Expenses is estimated to increase to about 1.4 M, while Interest Expense is projected to decrease to under 167.6 K. View More Fundamentals

Inari Stock Against Markets

Inari Medical Corporate Management

Angela JDGeneral SecretaryProfile
Tara DunnSenior DevelopmentProfile
John BorrellSenior SalesProfile
Kevin StrangeAccounting, FinanceProfile
Janet BykVP AccountingProfile
John CFAVice RelationsProfile
Karen SilvaVice AccountingProfile
When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(1.35)
Revenue Per Share
9.901
Quarterly Revenue Growth
0.214
Return On Assets
(0.03)
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.